Ark Genomic Revolution ETF (ARKG)

$70.11 0.82 (1.18%)

20:00 EDT ARKG Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 224.72M

PE Ratio -

EPS -

Volume (Avg. Vol.) 675,000

Day's Range 68.71 - 70.12

52-Week Range 24.00 - 76.22

Dividend & Yield N/A (N/A)

ARKG Stock Predictions, Articles, and Ark Genomic Revolution ETF News

From the Web

4 Sector ETFs That Have Doubled This Year

From Talk Markets Oct 23, 2020

While there have been winners in many corners of the space, we highlight four sector ETFs that have doubled so far this year:

A Student of Disruptive Innovation Bets on Tesla, Telehealth, and Genomics

From Barron's Oct 23, 2020

ARK Investment’s Cathie Wood is a student of disruption innovation. Why she thinks Tesla will leave ride-hailing leaders Uber and Lyft in a cloud of dust.

Why You Should Invest in Genomics ETFs

From Talk Markets Oct 15, 2020

Biotech ETFs have done quite well this year as many pharma and biotech companies are working on coronavirus vaccines, therapeutics, and testing.

Cathie Wood’s Fund Bought More Tesla After Shares Got ‘Slapped’

From Bloomberg Sep 18, 2020

The record plunge in Tesla Inc. that shaved $82 billion from its value in just one day dragged down Cathie Wood’s innovation ETF. For her, the rout in the fund’s biggest holding was the perfect reason to buy even more.

These 7 Funds Beat the Market Without Owning the FAAMG Stocks

From Barron's Aug 28, 2020

Facebook, Apple, Amazon, Microsoft, and Google parent Alphabet make up nearly a quarter of the S&P 500. It isn’t easy to beat the market without owning 25% of the market—but these funds have done so over the past several years.

5 Sector ETFs That Have Gained More Than 50% This Year

From Talk Markets Aug 17, 2020

Here are five ETFs from different sectors of the broad market that have outperformed and gained at least 50% so far this year.